Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Pharmacopsychiatry|May 25, 2006
Aripiprazole pharmacotherapy of borderline personality disorderA Mobascher, J Mobascher, V Schlemper, et al.Der Nervenarzt|September 1, 1995
[Optical and tactile hallucinosis as clinical onset of Creutzfeld-Jakob disease]A Heinz, L G Schmidt, G Winterer, et al.Biological Psychiatry|September 22, 2001
Event-related potentials and genetic risk for schizophreniaG Winterer, M F Egan, T Rädler, et al.Translational Psychiatry|June 14, 2012
Hippocampal subfields predict positive symptoms in schizophrenia: first evidence from brain morphometryS Kühn, F Musso, A Mobascher, et al.Pharmacopsychiatry|March 25, 2009
Distinct haplogenotypes of the dopamine D2 receptor gene are associated with non-smoking behaviour and daily cigarette consumptionC Wernicke, J Reese, A Kraschewski, et al.American Journal of Medical Genetics|April 17, 1999
Association analysis between a Cys23Ser substitution polymorphism of the human 5-HT2c receptor gene and neuronal hyperexcitabilityJ Samochowiec, M Smolka, G Winterer, et al.Psychiatric Genetics|February 24, 2001
Genetic variation of the glutamate transporter EAAT2 gene and vulnerability to alcohol dependenceT Sander, A Ostapowicz, J Samochowiec, et al.Neuropsychobiology|January 1, 1995
Bivariate global frequency analysis versus chaos theory. A comparison for sleep EEG dataM Ziller, K Frick, W M Herrmann, et al.Acta Psychiatrica Scandinavica|June 17, 2003
EEG phenotype in alcoholism: increased coherence in the depressive subtypeG Winterer, M-A Enoch, K V White, et al.Schizophrenia Research|May 10, 2001
An association between reduced interhemispheric EEG coherence in the temporal lobe and genetic risk for schizophreniaG Winterer, M F Egan, T Rädler, et al.Pageof 6